Anixa Biosciences is trading up 7.5% at $3.00 after hours, with the catalyst unclear. - No new company-specific announcement, earnings release, or clearly reported catalyst was identified. - Shares closed at $2.79 on September 22, 2026. - The latest major disclosure was a September 21 Australian patent protecting its breast cancer vaccine technology through 2040; reporting does not link it to the move. The Nasdaq Composite rose 0.45%, but the move should be rechecked for delayed news.